Cargando…
Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor
Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better tr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210284/ https://www.ncbi.nlm.nih.gov/pubmed/28097139 http://dx.doi.org/10.1155/2016/5621313 |
_version_ | 1782490853141381120 |
---|---|
author | Su, Yongmei Jia, Chen Chen, Ying |
author_facet | Su, Yongmei Jia, Chen Chen, Ying |
author_sort | Su, Yongmei |
collection | PubMed |
description | Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better treatment strategies. This paper gives a new mathematical model of tumor therapy with oncolytic virus and MEK inhibitor. Stable analysis was given. Because mitogen-activated protein kinase (MEK) can not only lead to greater oncolytic virus infection into cancer cells, but also limit the replication of the virus, in order to provide the best dosage of MEK inhibitors and balance the positive and negative effect of the inhibitors, we put forward an optimal control problem of the inhibitor. The optimal strategies are given by theory and simulation. |
format | Online Article Text |
id | pubmed-5210284 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-52102842017-01-17 Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor Su, Yongmei Jia, Chen Chen, Ying Biomed Res Int Research Article Tumors are a serious threat to human health. The oncolytic virus is a kind of tumor killer virus which can infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. Mathematical models can help us to understand the tumor-virus dynamics and find better treatment strategies. This paper gives a new mathematical model of tumor therapy with oncolytic virus and MEK inhibitor. Stable analysis was given. Because mitogen-activated protein kinase (MEK) can not only lead to greater oncolytic virus infection into cancer cells, but also limit the replication of the virus, in order to provide the best dosage of MEK inhibitors and balance the positive and negative effect of the inhibitors, we put forward an optimal control problem of the inhibitor. The optimal strategies are given by theory and simulation. Hindawi Publishing Corporation 2016 2016-12-21 /pmc/articles/PMC5210284/ /pubmed/28097139 http://dx.doi.org/10.1155/2016/5621313 Text en |
spellingShingle | Research Article Su, Yongmei Jia, Chen Chen, Ying Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title | Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_full | Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_fullStr | Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_full_unstemmed | Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_short | Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor |
title_sort | optimal control model of tumor treatment with oncolytic virus and mek inhibitor |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210284/ https://www.ncbi.nlm.nih.gov/pubmed/28097139 http://dx.doi.org/10.1155/2016/5621313 |
work_keys_str_mv | AT suyongmei optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor AT jiachen optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor AT chenying optimalcontrolmodeloftumortreatmentwithoncolyticvirusandmekinhibitor |